Items where authors include "Lannoy, M."

Article

Magayr, T.A., Song, X., Streets, A.J. orcid.org/0000-0002-4328-044X et al. (10 more authors) (2020) Global microRNA profiling in human urinary exosomes reveals novel disease biomarkers and cellular pathways for Autosomal Dominant Polycystic Kidney Disease. Kidney International, 98 (2). pp. 420-435. ISSN 0085-2538

Lannoy, M., Valluru, M.K., Chang, L. et al. (4 more authors) (2020) The positive effect of selective prostaglandin E2 receptor EP2 and EP4 blockade on cystogenesis in vitro is counteracted by increased kidney inflammation in vivo. Kidney International, 98 (2). pp. 404-419. ISSN 0085-2538

Omar, F., Findlay, J.E., Carfray, G. et al. (19 more authors) (2019) Small-molecule allosteric activators of PDE4 long form cyclic AMP phosphodiesterases. Proceedings of the National Academy of Sciences, 116 (27). pp. 13320-13329. ISSN 0027-8424

Fragiadaki, M., Lannoy, M., Themanns, M. et al. (5 more authors) (2017) STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease. Kidney International. ISSN 0085-2538

Proceedings Paper

Lannoy, M., Abdela-ali, F., Streets, A.J. orcid.org/0000-0002-4328-044X et al. (1 more author) (2016) SO053: Selective elective prostaglandin E2 receptor blockade for the treatment of autosomal dominant polycystic kidney disease. In: Nephrology Dialysis Transplantation. 53rd ERA-EDTA Congress, 21-24 May 2016, Vienna, Austria. Oxford University Press (OUP) , i22-i23.